The European Life Sciences Web Portal
This is a free web portal for the life sciences in Europe and Israel... » read more
- Microsaic Announces £5.4m Conditional Placing (2016-08-26)
Microsaic Systems plc (AIM: MSYS), the high technology company developing next generation mass spectrometry instruments, is pleased to announce that, following its earlier announcement, the Company has conditionally raised gross proceeds of £5.4 million through the...
- SpectralWorks Releases AnalyzerPro Version 5.3 (2016-08-26)
A significant update to our AnalyzerPro software was released on 24th August, 2016. Version 5.3 features the fastest processing speeds yet and has an updated user interface to allow quick and easy navigation to results. Repetitive actions can now be grouped toge...
- Denali Therapeutics Announces $130m Series B, Collaborations (2016-08-25)
Denali Therapeutics Inc. (“Denali”) today announced several critical milestones in the company’s growth, including its first Clinical Trial Application (“CTA”) to initiate a Phase 1 trial, previously undisclosed collaborations and licensing deals, and a $130 millio...
- F-Star Announces Collaboration with Denali Therapeutics (2016-08-25)
F-star, a biopharmaceutical company developing novel bispecific antibodies, announces a collaborative agreement with Denali Therapeutics Inc. (Denali), a biotechnology company focused on neurodegenerative disorders, to research and develop antibodies for the delive...
- Uniqure Reports Results 2016H1, Provides Corporate Update (2016-08-25)
~ Progress Across the Pipeline ~ Additional data on AMT-060 in Hemophilia B Expected Later this Year ~ Data from Sanfilippo B and Parkinson’s Disease Studies Expected in Q1 2017 ~ Strong Balance Sheet to Support Advancment of Programs uniQure N.V. (NA...
- BioLineRx, I-Bridge Capital Establish Chinese Joint Venture (2016-08-25)
JV will promote development and commercialization of Israeli-sourced therapeutic assets for Chinese healthcare market BioLineRx Ltd. (NASDAQ/TASE:BLRX), a clinical stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising ...
- TxCell Appoints Biogen’s Olivier Danos to SAB (2016-08-24)
SAB now composed of four world-leading immunology experts, including Prof. Zelig Eshhar, who recently received the Novartis Prize for Clinical Immunology TxCell SA (FR0010127662 – TXCL), a biotechnology company developing innovative, personalized cellular immu...
- AZ Sells Small Molecule Antibiotics Business to Pfizer (2016-08-24)
> Pfizer’s dedicated focus on infectious diseases will extend the reach of the antibiotics to more patients globally and maximise the potential of the late-stage, small molecule antibiotics business AstraZeneca today announced that it has entered into an agree...
- AMRI Licenses CRISPR-Cas9 Technology from Broad Institute (2016-08-23)
AMRI (NASDAQ: AMRI) today announced that it entered into a non-exclusive commercial license agreement with the Broad Institute of MIT and Harvard for the use of CRISPR-Cas9 gene editing technology and has completed several projects for its customers. The company wi...
- GE Healthcare Licenses T-Cell Reagents from StemCell (2016-08-23)
Exclusive licensing agreement will provide cGMP grade reagents to further enable development and manufacturing of cellular immunotherapies In a further step to build its portfolio for the rapidly-growing cell therapy industry, GE Healthcare today announced an ...
Life-Sciences-Europe.com is your doorway to the European life sciences!
[LSE] provides free, up-to-date and structured access to
in Europe and Israel.
Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSE] is 100% Made in Germany!Start here with the latest News!
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to firstname.lastname@example.org and simply fill the subject line with the word »LSE newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]